オハイオにおける脳腫瘍の臨床試験
オハイオ内の拠点で、脳腫瘍に関する23件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Cleveland Clinic Taussig Cancer Center, Cleveland
- Ohio State University, Columbus
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07326566SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT04923542Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07248228Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Cleveland Clinic, Cleveland
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05786924A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- UHHS-Chagrin Highlands Medical Center, Beachwood
- Indu and Raj Soin Medical Center, Beavercreek
- Strecker Cancer Center-Belpre, Belpre
- 他56件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04511013Development of MRF for Characterization of Brain Tumors After Radiotherapy
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Cleveland
被験者募集中健康なボランティア歓迎
18歳〜60歳 · 全性別 · 2026/09/15更新 · NCT06101069A Phase 1/1b Study of IAM1363 in HER2 Cancers
- University Hospital Cleveland Medical Center, Cleveland
- Cleveland Clinic, Cleveland
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Miami Valley Hospital South, Centerville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT05386108Targeted Pediatric High-Grade Glioma Therapy
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
被験者募集中観察研究
12 Months – 39 Years · 全性別 · 2026/09/08更新 · NCT05839379A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- The Ohio State University College of Medicine (OSUCOM), Columbus
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07428616Study of Olutasidenib and Temozolomide in HGG
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
被験者募集中第2相
12歳〜39歳 · 全性別 · 2026/09/01更新 · NCT06161974Study of Letrozole in Recurrent Gliomas
- University of Cincinnati, Cincinnati
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT03122197Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/06更新 · NCT01891318A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/06更新 · NCT07003542Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Nationwide Children's Hospital, Columbus
被験者募集中第2相
1歳〜26歳 · 全性別 · 2026/08/04更新 · NCT07680439Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Mayfield Brain and Spine, Cincinnati
- Kettering Health, Kettering
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/22更新 · NCT04427384REMASTer: REcurrent Brain Metastases After SRS Trial
- Cleveland Clinic, Cleveland
- Kettering Health, Kettering
被験者募集中
18歳以上 · 全性別 · 2026/06/18更新 · NCT05124912Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/11更新 · NCT05588453Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
被験者募集中第2相
12 Months – 39 Years · 全性別 · 2026/05/29更新 · NCT05843253Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06810544Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/08更新 · NCT05987644cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Cleveland Clinic, Cleveland
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Cleveland Clinic Akron General, Akron
- UHHS-Chagrin Highlands Medical Center, Beachwood
- Aultman Health Foundation, Canton
- 他17件
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/08更新 · NCT03418961ClinicalTrials.govより、2026/10/04時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。